Sodium glucose transporter 2 inhibitors versus metformin on cardiovascular and renal outcomes in patients with diabetes with low cardiovascular risk: A nationwide cohort study
Chang HC, Chen YY, Kuo TT, et al.
J Am Heart Assoc. Pub. Online 9 Apr 2024.
Leggi